Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
NCT03644303
Circulating Tumour DNA, Genital Diseases
Manchester, Manchester Greater, United Kingdom
View Trial DetailsNCT Number: NCT00733213
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.
* Target Group: Patients with locally advanced or metastatic prostate cancer. * The first 10 consecutive patients records that meet the entry criteria.
Looking for future studies?
Notify Me18 year and older
Male
Observational
Research Site, Athens, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Between 2002 - 2008
Time frame: Between 2002 - 2008
AstraZeneca
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03644303
Circulating Tumour DNA, Genital Diseases
Manchester, Manchester Greater, United Kingdom
View Trial DetailsNCT03218826
Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm
Aurora, Colorado, United States
View Trial DetailsNCT06379880
Breast Diseases, Breast Neoplasms
Vandœuvre-lès-Nancy, De, France
View Trial DetailsNCT05701007
Genital Diseases, Genital Diseases, Male
Helsinki, Finland
View Trial Details